| |
| |
|
| Insider
Information: |
Empfield James R. |
| Relationship: |
EVP, Drug Discovery |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
10,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
10,000 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
EVP, Drug Discovery |
2022-08-12 |
10,000 |
2017-08-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-08-12 |
4 |
S |
$38.08 |
$2,211,978 |
D/D |
(57,743) |
10,000 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-08-12 |
4 |
D |
$38.02 |
$275,911 |
D/D |
(7,257) |
67,743 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-08-12 |
4 |
OE |
$3.10 |
$275,750 |
D/D |
65,000 |
75,000 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-03-07 |
4 |
S |
$30.54 |
$1,003,475 |
D/D |
(32,853) |
10,000 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-03-07 |
4 |
D |
$30.23 |
$291,629 |
D/D |
(9,647) |
42,853 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-03-07 |
4 |
OE |
$6.76 |
$291,400 |
D/D |
42,500 |
51,805 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-03-04 |
4 |
S |
$30.79 |
$563,919 |
D/D |
(18,315) |
10,000 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-03-04 |
4 |
D |
$31.42 |
$210,043 |
D/D |
(6,685) |
28,315 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
EVP, Drug Discovery |
• – – |
2022-03-04 |
4 |
OE |
$8.40 |
$210,000 |
D/D |
25,000 |
35,000 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
SVP, Drug Discovery |
• – – |
2017-08-15 |
4 |
B |
$2.48 |
$24,824 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
